Efficient transduction of human neurons with an adeno-associated virus vector

Gene Therapy

Volumn 3, Issue 3, 1996, Pages 254-261

  Du, B ^a   Wu, P ^a   Boldt Houle, D M ^a   Terwilliger, E F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

galactosidase; AAV; Gene transfer; Human NT neuron

Indexed keywords

GENE PRODUCT;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA INTEGRATION; EXPRESSION VECTOR; GENE NUMBER; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TARGET CELL;

BASE SEQUENCE; CELLS, CULTURED; CYTOMEGALOVIRUS; DEPENDOVIRUS; DNA PRIMERS; GENES, IMMEDIATE-EARLY; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; NEURONS; PROMOTER REGIONS (GENETICS); TRANSDUCTION, GENETIC; VIRUS INTEGRATION;

EID: 0030000767     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994; 5: 793-801.
2. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992; 158: 97-131
3. Samulski RJ. Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Gen Develop 1993; 3: 74-80.
4. Walsh CE et al Gene therapy for human hemoglobinopathies. J Soc Exp Biol Med 1993, 204: 289-300.
5. Alexander IE, Russell DW, Miller AD DNA-damaging agents greatly increase the transduction of nondividing cells by adenoassociated virus vectors. J Virol 1994; 68: 8282-8287.
6. Chatterjee S et al. Adeno-association virus vectors for high efficiency gene transfer into primary human hematopoietic cells. Blood 1992; 80: (Suppl. 1): 167a.
7. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993; 90: 10613-10617.
8. Flotte TR, Afione SA, Zeitlin PL. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 1994; 11: 517-521.
9. Goodman S et al. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic cells. Blood 1994; 84: 1492-1500.
10. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
11. Podsakoff G, Wong KK Jr, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994; 68: 5656-5666.
12. Walsh CE et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994; 94: 1440-1448.
13. Russell DW, Miller AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994; 91: 8915-8919.
14. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995; 69: 1473-1479.
15. Breakefield XO. Gene delivery into the brain using virus vectors. Nat Genet 1993; 3: 187-189.
16. Geller AI, During MJ, Neve RL. Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci 1991; 11: 428-432.
17. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
18. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219-223.
19. Friedmann T. Gene therapy for neurological disorders. Trends Genet 1994; 10: 210-214.
20. Neve RL. Adenovirus vectors enter the brain. Trends Neurosci 1993; 16: 251-253.
21. Meyer EM et al. A novel gene delivery system for neuroactive peptides in brain tissue. In: Nagatsu T, Fisher A, Yoshida M (eds). Advances in Behavioral Biology. 1995; 44: 699-708.
22. Wu et al. Differential neuropeptide Y gene expression in post-mitotic versus dividing neuroblastoma cells driven by an adeno-associated virus vector. Mol Brain Res 1994; 24: 27-33.
23. Wu P et al. Sendai virosomal infusion of an adeno-associated virus-derived construct containing neuropeptide Y into primary rat brain cultures. Neurosci Lett 1995; 190: 73-76.
24. Lee V, McGrogan M, Lernhardt W, Huvar A. hNT neurons: human postmitotic CNS neurons. Strat Mol Biol 1994; 7: 28-31.
25. Pleasure SJ, Lee VM. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993; 35: 585-602.
26. Kurie JM et al. Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation. Differentiation 1993; 54: 115-122.
27. Kurie JM, Allopenna J, Dmitrovsky E. Retinoic acid stimulates protein kinase A-associated G proteins during human teratocarcinoma differentiation. Biochim Biophys Acta 1994; 1222: 88-94.
28. Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 1992; 12: 1802-1815.
29. Younkin DP et al. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc Natl Acad Sci USA 1993; 90: 2174-2178.
30. Hardy M et al. Expression of non-NMDA glutamate receptor channel genes by clonal human neurons. J Neurochem 1994; 63: 482-489.
31. Wertkin AM et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993; 90: 9513-9517.
32. Kimpton J, Emerman M. Detection of replication competent and pseudotyped HIV with a sensitive cell line based on activation of an integrated beta-galactosidase gene. J Virol 1992; 66: 2232-2239.
33. Zhou SZ et al. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol 1993; 21: 928-933.
34. Zhou SZ et al. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 1994; 179: 1867-1875.
35. Miller J et al. Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci USA 1994; 91: 10183-10187.
36. Samulski RJ, Chang L-S, Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol 1987; 61, 3096-3101.
37. Samulski RJ, Chang L-S, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
38. Williams JF. Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J Gen Virol 1970; 9: 251-255.
39. Kappes JC et al. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology 1993; 193: 222-233.
40. Wigler et al. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 1979; 76: 1373-1376.
41. Luthman H, Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells Nucleic Acids Res 1983; 11: 1295-1308.
42. Hall BL, Finn OJ. PCR-based analysis of usage within the T-cell receptor Vβ multigene family: considerations affecting the validity of the approach. Biotechniques 1992; 13 248-257.
43. Ehrlich GD, Greenberg S, Abbott MA. Detection of human T-cell lymphoma/leukemia viruses. In: Innis MA, Gelfand DH, Sninsky JT, White TJ (eds.) PCR Protocols: A Guide to Methods and Applications. Academic Press: San Diego, 1990, pp 325-336.